Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes [225Ac...
Q2 2026
Aug 13, 2026
Q1 2026
May 11, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q1 2025
Mar 31, 2025